Shares of Strides Pharma traded in positive in early trade on Wednesday as the company is set to receive US$42 million from Agila transaction.

Skipper, manufacturer of power transmission and distribution structures, has bagged an order worth Rs. 150 crore for 2,500 towers from multiple telecom operators

Pharma major Glenmark has received the final approval from United States Food and Drug Association (USFDA) for Fluocinolone Acetonide Oil, 0.01 per cent. The stock was trading 0.81 per cent higher.

Integrated construction company Ahluwalia Contracts surged as much as 7 per cent to touch intra-day high of around Rs. 305 apiece, after the company informed the bourses that it has bagged order worth nearly Rs.425.42 crore.

Ministry of Finance has increased the central government's NPS contribution for its employees to 14 per cent from the existing 10 per cent. The government has also tweaked the tax exemption limit for withdrawal on exit making it a Triple E investment plan.

IT giant Infosys gained on the bourses as the company declared the formation of a JV with Hitachi, Panasonic Corporation and Pasona Inc. Shares of the company gained almost 3 per cent intraday.

Strides Pharma’s step-down wholly-owned subsidiary, Strides Pharma Globe Pte. Limited, Singapore, received USFDA approval for Lidocaine Ointment. The stocks of Strides gained 2 per cent in the morning trading session.

Subsidiary of Hinduja Group, Ashok Leyland has signed an MoU with ELBIT Systems, Israel. The shares of the company gained more than 2 per cent intraday on Wednesday.

The stocks most likely to witness significant movement on the bourses on December 13 are ITC, Bandhan Bank, Jubilant FoodWorks, Pricol and Ramco Systems.

PNC Infratech’s wholly-owned subsidiary PNC Challakere (Karnataka) Highways Private Limited, has achieved financial closure by submitting duly executed financing documents to NHAI for the Hybrid Annuity Model (HAM) project.